Polly J Ferguson
Overview
Explore the profile of Polly J Ferguson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
2705
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhao Y, Oliver M, Schnabel A, Wu E, Wang Z, Marino A, et al.
Ann Rheum Dis
. 2025 Feb;
PMID: 39966038
The publisher regrets that this article has been temporarily removed. A replacement will appear as soon as possible in which the reason for the removal of the article will be...
2.
Syed H, Glennon S, Teferi N, Chenoweth D, Eschbacher K, Ferguson P, et al.
J Neurosurg Case Lessons
. 2025 Feb;
9(6).
PMID: 39928929
Background: Gorham-Stout disease (GSD) is an extremely rare osteolytic disorder characterized by resorption of skeletal bone due to aggressive, nonneoplastic lymphatic proliferation. Observations: The authors report the 14th case of...
3.
Lee S, Kim S, Segerstrom S, Ferguson P, Lenert A
J Clin Rheumatol
. 2025 Jan;
31(2):60-64.
PMID: 39823219
Objective: The aim of this study was to evaluate and validate the accuracy and performance characteristics of administrative codes in diagnosing autoinflammatory syndromes (AISs). Methods: We identified potential AIS patients...
4.
Rodriguez S, Sharma S, Tiarks G, Peterson Z, Jackson K, Thedens D, et al.
Sci Rep
. 2024 Jun;
14(1):13507.
PMID: 38867062
Traumatic Brain Injury (TBI) induces neuroinflammatory response that can initiate epileptogenesis, which develops into epilepsy. Recently, we identified anti-convulsive effects of naltrexone, a mu-opioid receptor (MOR) antagonist, used to treat...
5.
Charras A, Hofmann S, Cox A, Schulze F, Russ S, Northey S, et al.
J Autoimmun
. 2024 Feb;
144:103183.
PMID: 38401466
Chronic nonbacterial osteomyelitis (CNO), an autoinflammatory bone disease primarily affecting children, can cause pain, hyperostosis and fractures, affecting quality-of-life and psychomotor development. This study investigated CNO-associated variants in P2RX7, encoding...
6.
Li S, Rabinovich C, Becker M, Torok K, Ferguson P, Dedeoglu F, et al.
Arthritis Care Res (Hoboken)
. 2023 Dec;
76(5):616-626.
PMID: 38148547
Objective: Juvenile localized scleroderma (jLS) is a chronic autoimmune disease commonly associated with poor outcomes, including contractures, hemiatrophy, uveitis, and seizures. Despite improvements in treatment, >25% of patients with jLS...
7.
Todd B, Luo Z, Gilkes N, Chimenti M, Peterson Z, Mix M, et al.
Acta Neuropathol Commun
. 2023 Aug;
11(1):134.
PMID: 37596685
Accumulating evidence suggests that type I interferon (IFN-I) signaling is a key contributor to immune cell-mediated neuropathology in neurodegenerative diseases. Recently, we demonstrated a robust upregulation of type I interferon-stimulated...
8.
Ramachandran S, Zhao Y, Ferguson P
Curr Opin Rheumatol
. 2023 Jul;
35(5):255-264.
PMID: 37433220
Purpose Of Review: To review recent trends in treatment and recent progress in developing outcome measures needed for chronic nonbacterial osteomyelitis (CNO) clinical trials. Recent Findings: CNO is an autoinflammatory...
9.
Wu E, Oliver M, Scheck J, Lapidus S, Kaya Akca U, Yasin S, et al.
J Rheumatol
. 2023 Jul;
50(10):1333-1340.
PMID: 37399459
Objective: Prospective comparative effectiveness research (CER) in chronic nonbacterial osteomyelitis (CNO) is lacking. Our objectives were to (1) determine the use and safety of each consensus treatment plan (CTP) regimen...
10.
Todd B, Luo Z, Gilkes N, Chimenti M, Peterson Z, Mix M, et al.
bioRxiv
. 2023 Jun;
PMID: 37333385
Accumulating evidence suggests that type I interferon (IFN-I) signaling is a key contributor to immune cell-mediated neuropathology in neurodegenerative diseases. Recently, we demonstrated a robust upregulation of type I interferon-stimulated...